Ramsay Générale de Santé SA (EPA: GDS)
France
· Delayed Price · Currency is EUR
11.80
-0.20 (-1.67%)
Nov 12, 2024, 5:35 PM CET
Ramsay Générale de Santé Revenue
In the fiscal year ending June 30, 2024, Ramsay Générale de Santé had annual revenue of 5.01B EUR with 6.49% growth. Ramsay Générale de Santé had revenue of 1.31B in the quarter ending June 30, 2024, with 5.32% growth.
Revenue
5.01B
Revenue Growth
+6.49%
P/S Ratio
0.26
Revenue / Employee
146.31K
Employees
38,000
Market Cap
1.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 5.01B | 305.00M | 6.49% |
Jun 30, 2023 | 4.70B | 400.50M | 9.31% |
Jun 30, 2022 | 4.30B | 278.40M | 6.92% |
Jun 30, 2021 | 4.02B | 276.40M | 7.38% |
Jun 30, 2020 | 3.75B | 345.10M | 10.15% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac SA | 1.34B |
Vetoquinol SA | 537.47M |